Edit |   |
---|---|
Antigenic Specificity | MET, Human (Emibetuzumab biosimilar) |
Clone | Emibetuzumab |
Host Species | Recombinant Mouse |
Reactive Species | human |
Isotype | IgG4 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | FuncS, IF, Neut, ELISA, FCM, IP, WB, PK, Activ |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human MET Recombinant Antibody (Emibetuzumab). Emibetuzumab (INN) (LY2875358) is a humanized monoclonal antibody designed for the treatment of cancer. It is in phase II trials for patients with NSCLC. This drug was developed by Eli Lilly & Company. |
Immunogen | n/a |
Other Names | Anti-MET Recombinant Antibody, Research Grade Emibetuzumab, Anti-Human MET Recombinant Antibody(Emibetuzumab), LA480, LY-2875358, Antibody Drug Analogues, Monoclonal Antibody, YR1337, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1365287-97-3 |
Catalog # | YR1337 |
Price | please inquire |
Order / More Info | MET, Human (Emibetuzumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |